Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Australia
/
Pharmaceuticals & Biotech
Create a narrative
Aroa Biosurgery Community
ASX:ARX Community
1
Narratives
written by author
0
Comments
on narratives written by author
43
Fair Values set
on narratives written by author
Create a narrative
Aroa Biosurgery
Popular
Undervalued
Overvalued
Community Investing Ideas
Aroa Biosurgery
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Lebanon, Vietnam, And Saudi Arabia Approvals Will Secure Market Presence
Key Takeaways Expansion into international markets and positive clinical outcomes suggest potential revenue growth as new regions adopt Aroa's cost-effective products. Strategic investments in sales force and manufacturing operations aim to boost market share, production capacity, and adoption of diverse product offerings.
View narrative
AU$0.85
FV
48.1% undervalued
intrinsic discount
25.46%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
ARX
ARX
Aroa Biosurgery
Your Fair Value
AU$
Current Price
AU$0.44
71.8% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-19m
200m
2015
2018
2021
2024
2025
2027
2030
Revenue NZ$200.1m
Earnings NZ$39.5m
Advanced
Set Fair Value